Inhibitor Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 6,000,000 | 3.49% |
| Private Companies | 33,156,057 | 19.3% |
| Individual Insiders | 63,312,114 | 36.8% |
| General Public | 69,555,374 | 40.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 27,917,250 | US$3.4m | -1.24% | no data | |||
| 23,514,985 | US$2.8m | 0% | no data | |||
| 20,101,057 | US$2.4m | 0% | no data | |||
| 10,555,000 | US$1.3m | 0% | no data | |||
| 8,727,519 | US$1.1m | 0% | no data | |||
| 6,000,000 | US$723.7k | 0% | no data | |||
| 2,500,000 | US$301.6k | 0% | no data | |||
| 1,096,135 | US$132.2k | 15.9% | no data | |||
| 1,079,543 | US$130.2k | 4.86% | no data | |||
| 846,271 | US$102.1k | 5.69% | no data | |||
| 50,000 | US$6.0k | 0% | no data | |||
| 50,000 | US$6.0k | 0% | no data | |||
| 30,411 | US$3.7k | 0% | no data |